Given that IRAK4 is a common mediator of TLR signaling from the cell surface and from endosomes (Figure 1), the fact that all TLRs except TLR8 have been shown to influence BrCa progression (9) implicates IRAK4 as an accomplice. The gene discussed is TLR8; the disease is invasive breast carcinoma.